Date published: 2025-10-15

1-800-457-3801

SCBT Portrait Logo
Seach Input

CCDC96 Inhibitors

CCDC96 inhibitors comprise a class of chemical compounds specifically designed to target and inhibit the function of the coiled-coil domain containing 96 (CCDC96) protein. These inhibitors function by binding to the CCDC96 protein, thereby obstructing its interaction with other cellular components and pathways that are essential for its normal activity. The inhibition of CCDC96 can have a profound impact on the cellular processes in which it is involved, notably those related to intracellular signaling and structural maintenance. Since CCDC96 is implicated in a variety of cellular mechanisms, the inhibitors have to be precise in their action to avoid off-target effects that could disrupt cellular homeostasis. The design of these inhibitors takes into account the structural conformation of the CCDC96 protein, ensuring that they have high affinity and specificity for their target. The development of CCDC96 inhibitors is based on a deep understanding of the protein's role at the molecular level, including its interaction with other proteins and its part in signaling cascades. By binding to CCDC96, these inhibitors can prevent the protein from performing its normal functions, which may include mediating molecular interactions and facilitating certain biochemical pathways. The specificity of CCDC96 inhibitors is crucial; it allows for the precise downregulation of the protein's activity without interfering with other proteins that may have similar domains or functions. The molecular structure of these inhibitors is such that they can navigate the intracellular environment and reach the CCDC96 protein in its native context, ensuring that the inhibition is effective in the complex milieu of the cell. The precise mechanisms by which these inhibitors exert their effects are the subject of continued research, but their ability to selectively bind and inhibit CCDC96 is central to their functionality.

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

Rapamycin binds to FKBP12 and together they inhibit mTOR, which is crucial for protein synthesis and cell proliferation. As CCDC96 is involved in ciliogenesis and mTOR pathways intersect with ciliary processes, inhibition of mTOR could disrupt the functional activity of CCDC96 in ciliogenesis.

Wiskostatin

253449-04-6sc-204399
sc-204399A
sc-204399B
sc-204399C
1 mg
5 mg
25 mg
50 mg
$48.00
$122.00
$432.00
$812.00
4
(1)

WZB117 inhibits glucose transporter 1 (GLUT1), leading to decreased glucose uptake. Since ciliogenesis and the function of CCDC96 are energy-dependent processes, the reduced energy supply could indirectly impair CCDC96's function.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

LY294002 is a PI3K inhibitor, which prevents the phosphorylation of PIP2 to PIP3, a step necessary for AKT activation. Since PI3K/AKT pathway can regulate ciliogenesis, and potentially CCDC96's role within it, LY294002 may indirectly inhibit CCDC96's function.

PD173074

219580-11-7sc-202610
sc-202610A
sc-202610B
1 mg
5 mg
50 mg
$46.00
$140.00
$680.00
16
(1)

PD173074 is an FGFR inhibitor. Even though FGFR proteins were excluded, this compound does not target the protein directly but inhibits its receptor's tyrosine kinase activity, which could have downstream effects on the signaling pathways that CCDC96 is involved in.

Taxol

33069-62-4sc-201439D
sc-201439
sc-201439A
sc-201439E
sc-201439B
sc-201439C
1 mg
5 mg
25 mg
100 mg
250 mg
1 g
$40.00
$73.00
$217.00
$242.00
$724.00
$1196.00
39
(2)

Paclitaxel stabilizes microtubules and thereby can interrupt microtubule dynamics, which is essential for ciliogenesis and the function of CCDC96 within this process. By preserving microtubule polymerization, it could indirectly hinder CCDC96's role in cilia formation.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Mitomycin C is a DNA crosslinker that can lead to the inhibition of DNA synthesis and cell division. Since CCDC96 is involved in ciliogenesis, processes that are affected by cell cycle dynamics, Mitomycin C might indirectly reduce the functional activity of CCDC96 by disrupting cell cycle-dependent ciliary processes.

Cyclopamine

4449-51-8sc-200929
sc-200929A
1 mg
5 mg
$92.00
$204.00
19
(1)

Cyclopamine is a hedgehog signaling pathway inhibitor that suppresses smoothened (SMO) activity. The hedgehog pathway is implicated in ciliogenesis, and as such, Cyclopamine could indirectly inhibit CCDC96 by hindering a pathway critical for its function.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$65.00
$162.00
$650.00
$2550.00
109
(2)

Concanamycin A is a specific inhibitor of V-ATPase. Disrupting the proton pump affects the acidification of organelles and can interrupt trafficking to the cilia. This could indirectly impact CCDC96's role in ciliogenesis by altering the cellular environment necessary for cilia assembly and maintenance.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$30.00
$52.00
$122.00
$367.00
25
(3)

Brefeldin A disrupts Golgi apparatus structure and function, which is key in protein sorting and trafficking to the cilia. This compound could indirectly inhibit CCDC96 by impairing ciliary protein trafficking necessary for its activity.

rac Perhexiline Maleate

6724-53-4sc-460183
10 mg
$184.00
(0)

Perhexiline inhibits carnitine palmitoyltransferase-1 (CPT1), which is crucial for mitochondrial fatty acid uptake and beta-oxidation. Since ciliogenesis and CCDC96's function might depend on energy balance, Perhexiline could indirectly inhibit CCDC96 by disrupting cellular energy metabolism.